1 | English French Notes Complete/Exclude
|
---|
2 | Venous Invasion (V):
|
---|
3 | Other Stage:
|
---|
4 | Physician Staging:
|
---|
5 | Tumor Size:
|
---|
6 | Pathologic Extension:
|
---|
7 | Lymph Nodes:
|
---|
8 | Metastasis 1:
|
---|
9 | Regional Nodes Examined:
|
---|
10 | Metastasis 2:
|
---|
11 | Regional Nodes Positive:
|
---|
12 | Metastasis 3:
|
---|
13 | General Summary Stage:
|
---|
14 | Peripheral Blood Involvement:
|
---|
15 | Associated With HIV:
|
---|
16 | Surgical Dx/Staging Proc:
|
---|
17 | Surgical Dx/Staging Proc Date:
|
---|
18 | Surg Dx/Staging Proc @Fac:
|
---|
19 | Surg Dx/Staging Proc @Fac Date:
|
---|
20 | Date of no treatment:
|
---|
21 | Surgery of Primary (R):
|
---|
22 | Surgery of Primary (F):
|
---|
23 | Surgery of Primary Date:
|
---|
24 | Surgery of Primary @Fac (R):
|
---|
25 | Surgery of Primary @Fac (F):
|
---|
26 | Surgery of Primary @Fac Date:
|
---|
27 | Surgical Approach (R):
|
---|
28 | Surgical Margins:
|
---|
29 | Scope of LN Surgery (R):
|
---|
30 | Scope of LN Surgery (F):
|
---|
31 | Scope of LN Surgery Date:
|
---|
32 | Scope of LN Surgery @Fac (R):
|
---|
33 | Scope of LN Surgery @Fac (F):
|
---|
34 | Scope of LN Surgery @Fac Date:
|
---|
35 | Surg Proc/Other Site (R):
|
---|
36 | Surg Proc/Other Site (F):
|
---|
37 | Surg Proc/Other Site Date:
|
---|
38 | Surg Proc/Other Site @Fac (R):
|
---|
39 | Surg Proc/Other Site @Fac (F):
|
---|
40 | Surg Proc/Other Site @Fac Date:
|
---|
41 | Date of Surgical Discharge:
|
---|
42 | Reason for No Surgery:
|
---|
43 | RX Text-Surgery:
|
---|
44 | Date Radiation Started:
|
---|
45 | Location of Radiation Tx:
|
---|
46 | Radiation Treatment Volume:
|
---|
47 | Regional Treatment Modality:
|
---|
48 | Regional Dose: cGy:
|
---|
49 | Boost Treatment Modality:
|
---|
50 | Boost Dose: cGy:
|
---|
51 | Number of Txs to this Volume:
|
---|
52 | Date Radiation Ended:
|
---|
53 | Radiation @Fac Date:
|
---|
54 | Radiation/Surgery Sequence:
|
---|
55 | Reason for No Radiation:
|
---|
56 | RX Text-Radiation (Beam):
|
---|
57 | RX Text-Radiation Other:
|
---|
58 | Chemotherapy Date:
|
---|
59 | Chemotherapy @Fac Date:
|
---|
60 | RX Text-Chemo:
|
---|
61 | Hormone Therapy:
|
---|
62 | Hormone Therapy Date:
|
---|
63 | Hormone Therapy @Fac:
|
---|
64 | Hormone Therapy @Fac Date:
|
---|
65 | RX Text-Hormone:
|
---|
66 | Immunotherapy Date:
|
---|
67 | Immunotherapy @Fac Date:
|
---|
68 | RX Text-BRM:
|
---|
69 | Hema Trans/Endocrine Proc:
|
---|
70 | Hema Trans/Endocrine Proc Date:
|
---|
71 | Other Treatment:
|
---|
72 | Other Treatment Date:
|
---|
73 | Other Treatment @Fac:
|
---|
74 | Other Treatment @Fac Date:
|
---|
75 | RX Text-Other:
|
---|
76 | Pain Assessment:
|
---|
77 | Palliative Procedure:
|
---|
78 | Palliative Procedure @Fac:
|
---|
79 | Protocol Participation:
|
---|
80 | Year Put on Protocol:
|
---|
81 | Text Dx Proc-Phys.Exam:
|
---|
82 | Text Dx Proc-Xray/Scan:
|
---|
83 | Text Dx Proc-Operations:
|
---|
84 | Text Dx Proc-Lab Tests:
|
---|
85 | Text Dx Proc-Endoscopy:
|
---|
86 | Text Dx Proc-Path/Cyto:
|
---|
87 | Date of First Recurrence:
|
---|
88 | Type of First Recurrence:
|
---|
89 | Distant Site 1:
|
---|
90 | Distant Site 2:
|
---|
91 | Distant Site 3:
|
---|
92 | Subsequent Recurrence Date:
|
---|
93 | Type of Subsequent Recurrence:
|
---|
94 | SUBSEQUENT COURSE OF THERAPY
|
---|
95 | Date Started:
|
---|
96 | Surgery of Primary Site:
|
---|
97 | Scope of Lymph Node Surg:
|
---|
98 | Number of Nodes Removed:
|
---|
99 | Surgery of Other Sites/Nodes:
|
---|
100 | Radiation Sequence:
|
---|
101 | Radiation Therapy to CNS:
|
---|
102 | OTHER PRIMARY SITES
|
---|
103 | Abst Status
|
---|
104 | No Other Primary Sites
|
---|
105 | PERSONAL DATA
|
---|
106 | Address at Dx:
|
---|
107 | Address at Dx - Supp:
|
---|
108 | City/Town at Dx:
|
---|
109 | Place of Birth:
|
---|
110 | State at Dx:
|
---|
111 | Postal Code at Dx:
|
---|
112 | Marital Status at Dx:
|
---|
113 | County at Dx:
|
---|
114 | Primary Payer at Dx:
|
---|
115 | Next of Kin:
|
---|
116 | Abstract Status :
|
---|
117 | Abstract Date:
|
---|
118 | Abstracted by:
|
---|
119 | Agent Orange Exposure:
|
---|
120 | Ionizing Radiation Exposure:
|
---|
121 | Chemical Exposure:
|
---|
122 | Asbestos Exposure:
|
---|
123 | Persian Gulf Service:
|
---|
124 | Middle East Service:
|
---|
125 | Somalia Service:
|
---|
126 | Comorbidity/Complication #1:
|
---|
127 | Comorbidity/Complication #2:
|
---|
128 | Comorbidity/Complication #3:
|
---|
129 | Comorbidity/Complication #4:
|
---|
130 | Comorbidity/Complication #5:
|
---|
131 | Comorbidity/Complication #6:
|
---|
132 | EMPLOYMENT HISTORY
|
---|
133 | Usual Industry:
|
---|
134 | TOBACCO AND ALCOHOL USAGE
|
---|
135 | TOBACCO HISTORY:
|
---|
136 | Type of Tobacco User:
|
---|
137 | CHEWING TOBACCO
|
---|
138 | MORE THAN 1 TYPE
|
---|
139 | Pack-Years:
|
---|
140 | Year Quit Tobacco Use:
|
---|
141 | ALCOHOL HISTORY:
|
---|
142 | Type of Alcohol User:
|
---|
143 | HARD LIQUOR
|
---|
144 | MODERATE/SOCIAL
|
---|
145 | SERIOUS/HEAVY
|
---|
146 | Years of Alcohol Use:
|
---|
147 | Drinks Per Day:
|
---|
148 | Year Quit Drinking:
|
---|
149 | CANCER FAMILY HISTORY:
|
---|
150 | Family member with cancer:
|
---|
151 | PHYSICIAN CONTACTS
|
---|
152 | Following Physician:
|
---|
153 | Primary Surgeon:
|
---|
154 | QA Selected:
|
---|
155 | QA Reviewer:
|
---|
156 | QA Date:
|
---|
157 | QA Review:
|
---|
158 | QA Findings:
|
---|
159 | FOLLOW-UP HISTORY
|
---|
160 | Date of Last Contact:
|
---|
161 | Last Tumor Status:
|
---|
162 | Date of Death:
|
---|
163 | Cause of Death:
|
---|
164 | ICD Cause of Death:
|
---|
165 | State Death Cert:
|
---|
166 | ICD Revision:
|
---|
167 | Place of Death:
|
---|
168 | Care Center at Death:
|
---|
169 | Autopsy Date/Time:
|
---|
170 | Autopsy No.:
|
---|
171 | TUMOR Status at DEATH (Multiple Primaries)
|
---|
172 | Last Contact:
|
---|
173 | Follow-up Method:
|
---|
174 | Readmission (inpatient or outpatient)
|
---|
175 | Vital Status:
|
---|
176 | Next Follow-up Method:
|
---|
177 | Quality of Survival:
|
---|
178 | Unusual Follow-up Method:
|
---|
179 | 1st unusual method
|
---|
180 | 2nd unusual method
|
---|
181 | Date Entered:
|
---|
182 | Registrar:
|
---|
183 | Following Registry:
|
---|
184 | Select year
|
---|
185 | @#ACCESSION YEAR,ACC/SEQ NUMBER
|
---|
186 | ANNUAL Patient Index - ACOS Required (132col)
|
---|
187 | #@ACCESSION YEAR,@PATIENT NAME
|
---|
188 | ANNUAL Patient List by Class of Case (80c)
|
---|
189 | @ACCESSION YEAR,+#@CLASS CATEGORY,+CLASS OF CASE,@PATIENT NAME
|
---|
190 | ANNUAL Site/Gp Listing by ICDO-Topography/Histology
|
---|
191 | @ACCESSION YEAR,+@CLASS CATEGORY,#SITE/GP;S1;C20,+ICDO-TOPOGRAPHY;C12,+HISTOLOGY (ICD-O-2);C9
|
---|
192 | ANNUAL Site/GP Index by ICDO-Topography (132)
|
---|
193 | @ACCESSION YEAR,@CLASS CATEGORY,#@SITE/GP
|
---|
194 | Annual report - sorted first by Accession year
|
---|
195 | Then by Class Category (Non-analytic/Analytic)
|
---|
196 | Then by Status, Site/GP, and Diagnosis Age Gp.
|
---|
197 | Enter four digit ACCESSION YEAR,
|
---|
198 | for Class category: either 'A'
|
---|
199 | for Analytic, or first to last.
|
---|
200 | YOU may customize your own reports using this option
|
---|
201 | See the FileManager Manual for detailed instructions
|
---|
202 | CREATE CUSTOM REPORT for
|
---|
203 | There is no ICDO-TOPOGRAPHY for this primary.
|
---|
204 | There is currently no PCE for this primary site
|
---|
205 | nor is it a 1997 Non-Hodgkin's Lymphoma or 1999
|
---|
206 | Melanoma.
|
---|
207 | '00/00/00' is ambiguous, enter a 4 digit year.
|
---|
208 | '88/88/88' is ambiguous, enter a 4 digit year.
|
---|
209 | '99/99/99' is ambiguous, enter a 4 digit year.
|
---|
210 | LOOKING FOR Address at Diagnosis - Get from MAS
|
---|
211 | DONE CONVERTING ADDRESS AT DX
|
---|
212 | Select Type Abstract
|
---|
213 | Select Option
|
---|
214 | Select Patient to Print:
|
---|
215 | ALL PATIENT ABSTRACTS
|
---|
216 | Select Site/GP to Print:
|
---|
217 | ONCOLOGY MULTIPLE SITE ABSTRACTS
|
---|
218 | Select Site/GP:
|
---|
219 | SITE GPS for 19
|
---|
220 | Timed out...
|
---|
221 | ALL ABSTRACTS for 19
|
---|
222 | Select Beginning Date:
|
---|
223 | Choose Ending Date:
|
---|
224 | ONCOD*
|
---|
225 | ABSTRACTS BY DXDT
|
---|
226 | Define an AUTHORIZED QA USER in the ONCOLOGY SITE PARAMETERS file
|
---|
227 | Not an AUTHORIZED QA USER
|
---|
228 | Time frame: ABSTRACT DATE (Completed)
|
---|
229 | Select Beginning Date
|
---|
230 | Choose Ending Date
|
---|
231 | 10% QA REPORT-1
|
---|
232 | 10% QA REPORT-2
|
---|
233 | CANNOT DELETE THIS ENTRY
|
---|
234 | ONCO ABSTRACT NOT-COMPLETE
|
---|
235 | ONCO ACCREG-ACOS80
|
---|
236 | ONCO ACCREG-EOVA132
|
---|
237 | ONCO ACCREG-SITE/GP80
|
---|
238 | ONCO ACOS DOCUMENTATION
|
---|
239 | ONCO AJCC SUMMARY STAGE GPS
|
---|
240 | ONCO ANNUAL ACCREG80
|
---|
241 | ONCO ANNUAL ACCREG80-HDR
|
---|
242 | ONCO ANNUAL CLASS/PATIENT
|
---|
243 | ONCO ANNUAL CLASS/PATIENT-HDR
|
---|
244 | ONCO ANNUAL HIST/SITE/ICDO
|
---|
245 | ONCO ANNUAL ICDO/STAGE/TX
|
---|
246 | ONCO ANNUAL PATIENT INDX
|
---|
247 | ONCO ANNUAL PATIENT INDX-HDR
|
---|
248 | ONCO ANNUAL PATIENT INFO
|
---|
249 | ONCO ANNUAL PATIENT INFO-HDR
|
---|
250 | ONCO ANNUAL SITE/GP
|
---|
251 | ONCO ANNUAL SITE/GP-HDR
|
---|
252 | ONCO ANNUAL SITE/ICDT/ICDM
|
---|
253 | ONCO ANNUAL SITE/STAGE/TX
|
---|
254 | ONCO ANNUAL SITE/STAGE/TX-HDR
|
---|
255 | ONCO ANNUAL SITE/STG/TX
|
---|
256 | ONCO ANNUAL TREATMENT
|
---|
257 | ONCO CASEFINDING-HDR
|
---|
258 | ONCO CONTACT LIST-A
|
---|
259 | ONCO CONTACT LIST-T
|
---|
260 | ONCO DELINQUENT(LTF) LIST
|
---|
261 | ONCO DUE FOLLOWUP
|
---|
262 | ONCO DUE FOLLOWUP-ADM/DIS
|
---|
263 | ONCO DUE FOLLOWUP-ADM/DIS-HDR
|
---|
264 | ONCO DUE FOLLOWUP-HDR
|
---|
265 | ONCO DUE FOLLOWUP/TERMDIG
|
---|
266 | ONCO DUE FOLLOWUP/TERMDIG-HDR
|
---|
267 | ONCO F/U HISTORY (NEW)
|
---|
268 | ONCO FOLLOW-UP STATUS LIST
|
---|
269 | ONCO FOLLOWUP HISTORY
|
---|
270 | ONCO FOLLOWUP HISTORY-HDR
|
---|
271 | ONCO FOLLOWUP PATIENT RPT
|
---|
272 | ONCO FOLLOWUP PATIENT RPT-HDR
|
---|
273 | ONCO FOLLOWUP STATUS RPT
|
---|
274 | ONCO ICDO PATIENT LIST
|
---|
275 | ONCO ICDO-SITE132
|
---|
276 | ONCO ICDO-SITE132-HDR
|
---|
277 | ONCO ICDO-SITE80
|
---|
278 | ONCO ICDO-SITE80-HDR
|
---|
279 | ONCO LAB-CASEFINDING REPORT
|
---|
280 | ONCO LAB-CASEFINDING-HDR
|
---|
281 | ONCO NEG-REPORT
|
---|
282 | ONCO PATIENT INDX-ACOS
|
---|
283 | ONCO PATIENT INDX-ACOS-HDR
|
---|
284 | ONCO PATIENT INDX-EOVA132
|
---|
285 | ONCO PATIENT INDX80
|
---|
286 | ONCO PATIENT ONLY
|
---|
287 | ONCO PATIENT ONLY-HDR
|
---|
288 | ONCO PRIMARY EXTENT CODE AUDIT
|
---|
289 | ONCO PRIMARY INFORMATION132
|
---|
290 | ONCO PRIMARY SURGERY AUDIT
|
---|
291 | ONCO PTF-CASEFINDING RPT
|
---|
292 | ONCO PTF-CASEFINDING-HDR
|
---|
293 | ONCO RAD-CASEFINDING RPT
|
---|
294 | ONCO RAD-CASEFINDING-HDR
|
---|
295 | ONCO SITE HEADING
|
---|
296 | ONCO SITE-QA REPORT
|
---|
297 | ONCO SITE/GP80
|
---|
298 | ONCO SITE/GP80-HDR
|
---|
299 | ONCO SITE80
|
---|
300 | ONCO SITE80-HEADER
|
---|
301 | ONCO SUSPENSE
|
---|
302 | ONCO SUSPENSE-ALL/TERMDIG
|
---|
303 | #################### #################### ####################
|
---|
304 | #################### #################### ####################
|
---|
305 | #################### #################### ####################
|
---|
306 | #################### #################### ####################
|
---|
307 | #################### #################### ####################
|
---|